top of page
Our Technology
We are a cutting-edge biotech startup specializing in computational drug design, offering streamlined, high-value partnerships to accelerate drug discovery and development. Our expertise spans the entire R&D process from target identification through in vitro efficacy testing, with a relentless focus on innovation, precision, and efficiency.
Leveraging advanced AI-driven platforms and computational modeling, we identify and validate novel therapeutic targets with unparalleled speed and accuracy. Our capabilities extend across diverse therapeutic areas and modalities, with a strong emphasis on small molecules.
Our proprietary platforms integrate machine learning, structural biology, and cheminformatics to optimize hit-to-lead processes and predict clinical outcomes.
Our Platform
The above represented scheme is a generalised workflow, does not represent all the steps, processes and techniques that are applied at Discovera, moreover does not specify which are proprietary techniques or licensed algorithms.
Future Perspectives
Quantum computing
Our vision is to integrate quantum computing into our computational drug design framework, unlocking unprecedented capabilities in molecular modeling, target identification, and optimization.
​
Our commitment to staying at the forefront of innovation positions us to be early adopters of quantum technology, collaborating with leading quantum computing providers to pilot its application in drug discovery. By embracing this emerging technology, we aim to redefine the boundaries of what is possible in R&D, paving the way for groundbreaking therapies to reach patients faster.
+39 3336038046
bottom of page